The United Nations World Health Organization (WHO) has organized the supply of two million doses of yellow fever vaccine to Paraguay as health authorities in the South American country battle a deadly outbreak of the viral disease.

The vaccine doses were obtained from the WHO's International Coordinating Group on Provision of Vaccines, the agency said in an update released today. Brazil has sent 850,000 doses and Peru has dispatched 144,000, adding to the 300,000 that Paraguay already has on reserve

Another student at Bentley College in Massachusetts has been diagnosed with bacterial meningitis, barely five months after a first case was confirmed. The student, who was not identified, has been moved out of an intensive care unit and is recuperating.

Michelle Walsh, a Bentley College spokeswoman said that the school was very aggressive in tracking down anyone who had close contact with the sick student and about 200 students were given antibiotics as a precautionary measure

Elderly patients with advanced dementia are seven times more likely to receive antibiotics in their last two weeks of life, a Harvard study reports. Though there is little evidence that the drugs relieve suffering of such patients or increase their life span, the study says that excessive use of the drugs can contribute to the development of microbes resistant to antibiotics, a public-health hazard common in nursing homes.

Researchers from Harvard Medical School studied more than 214 patients with an average age of 85 in 21 Boston-area nursing homes. Almost half died during the 18-month study that time. These patients also failed to recognize loved ones, sized to communicate and were unable to walk or feed themselves

Health authorities in Uganda have declared the Ebola hemorrhagic fever outbreak in the country is over.

According to a World Health Organization statement Thursday, the last person in Uganda infected by the deadly virus was discharged from a hospital on Jan. 8. No incident of the disease occurred after that date or after 42 days, which is twice the maximum Ebola incubation period of 21 days

The U.S. Food and Drug Administration has approved Xyntha, a Wyeth drug Thursday to prevent and control bleeding in patients with hemophilia, a rare blood-clotting disorder. Xyntha, is a genetically engineered version of a blood protein that's essential for clotting.

Hemophilia is a rare, inherited bleeding disorder in which your blood doesn't clot normally. In hemophiliacs, the protein, called factor VIII, is missing or its effectiveness is decreased